This news about treating more patients in phase ll is huge .The FDA would never have allowed it if it wasn't safe and if it didn't show efficacy in the first trials
Many people including myself can complain about the way the FDA runs their trials but when they look at evidence and give approvals they show the world how good a specific treatment is ..
Neuralstem is for real .
Dr. Eva Feldman is for real .
Dr. Nick Boulis is for real
Dr. Jonathan Glass is for real
The rest of the entire Neuralstem team including the management that is continually lambasted .
Lou Gehrig's dreaded disease will be put on " The Remember When List " like Polio and so many other incurable diseases of .yesteryear .
Buy more before it gets out of range and CUR is known as CURe .
Definitely a small window of opportunity to buy near the low today, and I agree that buying yesterday in the $2.20's was a good deal. At $2.40 now, CUR is up 16% from this morning's lows. Moving up fast!
Thanks Razar1024. I think there's still a small chance it pulls back one more time, but I don't see it going below $2.02/share. I think CUR will be back to the $3's by Halloween, or very soon after. Also still think it reaches $4-5/share between now and the end of March 2014 (i.e. within about six months). Just predictions, not guarantees.